Justification of Biowaiver for Carbamazepine, a Low Soluble High Permeable Compound, in Solid Dosage Forms Based on IVIVC and Gastrointestinal Simulation-Reference-Cited by-同舟云学术

Justification of Biowaiver for Carbamazepine, a Low Soluble High Permeable Compound, in Solid Dosage Forms Based on IVIVC and Gastrointestinal Simulation

Published:2008-11-26 Issue:1 Volume:6 Page:40-47
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Kovačević Ivan¹,Parojčić Jelena¹,Homšek Irena¹,Tubić-Grozdanis Marija¹,Langguth Peter¹

Affiliation:

1. Medicines and Medical Devices Agency of Serbia, Vojvode Stepe 458, Belgrade, Serbia, Institute of Pharmaceutical Technology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, Belgrade, Serbia, Galenika, R&D Institute, Batajnicki drum bb, Belgrade, Serbia, and Department of Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg-University Mainz, Staudingerweg 5, D-55099 Mainz, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp800128y

Reference20 articles.

1. FDA/CDER Guidance for industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products—General Considerations, 2003.

2. EMEA/CPMP Note for guidance on the investigation of bioavailability and bioequivalence, 2001.

3. A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals

4. Feasibility of Biowaiver Extension to Biopharmaceutics Classification System Class III Drug Products

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biowaiver based on biopharmaceutics classification system: Considerations and requirements;Pharmaceutical Science Advances;2024-12

2. Polymorphism and Pharmacological Assessment of Carbamazepine;International Journal of Molecular Sciences;2024-09-11

3. Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes;Pharmaceutics;2024-05-30

4. Pharmacokinetic and Pharmacodynamic Modeling (PK/PD) in Pharmaceutical Research: Current Research and Advances;Software and Programming Tools in Pharmaceutical Research;2024-03-19

5. APPROACHES ON SURROGATE METHODS FOR IN VIVO BIOEQUIVALENCE STUDY OF FORMULATED BILAYER TABLETS OF DOMPERIDONE AND ITOPRIDE;International Journal of Applied Pharmaceutics;2024-03-07